Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 42 results for "Zegerid"

New and Generic Drug Approvals: Zegerid

ZEGERID OMEPRAZOLE; SODIUM BICARBONATE 20MG/PACKET; 1.68GM/PACKET FOR SUSPENSION;ORAL Prescription No ... U.S. Food and Drug Administration, 1 month ago

2 images for "Zegerid"

Drug Store News, 2 months ago
Drug Store News, 4 months ago

ViiV Healthcare launches phase III programme to evaluate a long-acting, injectable HIV treatment regimen

PRESS RELEASE Studies will investigate monthly dosing with injectable cabotegravir and rilpivirine ...
 National AIDS Treatment Advocacy Project19 hours ago GLAXOSMITHKLINE : ViiV Healthcare launches phase III programme to evaluate a long-acting, injectable HIV treatment regimen  4 Traders2 weeks ago ViiV starts PhIII LA injectable treatment regimen  Shares Magazine2 weeks ago GlaxoSmithKline PLC ViiV starts PhIII LA injectable treatment regimen  ADVFN UK2 weeks ago
Seeking Alpha

Valeant: Change Is Good

Fellow contributor Giovanni DiMauro published a bearish take on Valeant Pharmaceuticals (NYSE: VRX ) with which I strongly disagree. I'll start by going over DiMauro's points (between quotes) where I hold a variant view and summarize my bullish take ...
 Seeking Alpha1 week ago Why I Am Reversing My Position Of Valeant Pharmaceuticals  Seeking Alpha1 week ago Valeant Pharmaceuticals: Catching A Falling Knife Safely?  Seeking Alpha2 weeks ago Edited Transcript of VRX.TO earnings conference call or presentation 8-Nov-16 1:00pm GMT  Yahoo! Finance3 weeks ago
Yahoo! Canada

Long-Term Investors: Valeant Pharmaceuticals Intl Inc. Looks to Ease Debt Burden

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is in the news again. It's making a big move aimed at reducing its massive debt burden. The company is in talks with Japan's Takeda Pharmaceutical Co., one of two potential bidders for Salix, a ...
 Yahoo! Canada2 weeks ago

With Valeant's Continued Deterioration, Rodman & Renshaw Downgrades To Neutral

Valeant Pharmaceuticals Intl Inc (NYSE: VRX ) reported its Q3 revenue and earnings short of expectations. The company's sales could decline in 2017, partly due to competition from generic products, Rodman & Renshaw's Raghuram Selvaraju said in a ...
 Benzinga.com3 weeks ago

VALEANT PHARMACEUTICALS INTERNATIONAL, INC. - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations

RESTATEMENT The accompanying Management's Discussion and Analysis of Financial Condition and Results of Operations gives effect to the restatement adjustments made to the previously reported unaudited consolidated financial statements (see Note 2 ...
 Pharmacy Choice3 weeks ago

VALEANT PHARMACEUTICALS INTL : confirms it's in talks to potentially sell Salix stomach drug business

MONTREAL — Valeant Pharmaceuticals said Tuesday it's in discussion that may lead to the sale of its core stomach drug business Salix. The comment was issued in response to published reports that the drugmaker is in advanced talks to sell Salix ...
 4 Traders1 month ago Valeant confirms it's in talks to potentially sell Salix stomach drug business  News 11301 month ago
[x]  

Payers, patients target pricey meds that combo cheap generics

It's been a tried-and-true tactic for drugmakers for years: Take an aging drug and combine it with another aging drug, and voila! Brand-new, patent-protected product. It might face generics earlier than newly developed drugs, but unlocking sales ...
 FiercePharma1 month ago
Yahoo! Singapore

Proton Pump Inhibitor Lawsuit Plaintiffs Seek Consolidation of Federal Kidney Injury Claims, Bernstein Liebhard LLP Reports

NEW YORK, Oct. 19, 2016 /PRNewswire/ -- Plaintiffs who allegedly suffered serious kidney injuries, including chronic kidney disease or kidney failure, related to the use of Nexium or another proton pump inhibitor have asked a judicial panel to ...
 TickerTech.com1 month ago As Proton Pump Inhibitor Lawsuits Mount, Bernstein Liebhard LLP Notes New Study Suggesting Many Long-Term Users Continue to Struggle with GERD Symptoms  4 Traders1 month ago
[x]  

Kotak puts Sell rating on Dr Reddy's Laboratories; here's why

While the stock's re-rated on account of hopes on several fronts, the pipeline isn't sufficient to offset competitive pressures on the US biz. DRRD shares re-rated by 10% post Q1FY17 correction on hopes of earnings accretion from Teva portfolio ...
 Financial Express2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Zegerid
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less